Market revenue in 2023 | USD 107.8 million |
Market revenue in 2030 | USD 158.1 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.46% in 2023. Horizon Databook has segmented the Denmark diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Denmark holds a broad scope for design & innovation expertise, R&D collaborations, demonstration & test facilities, high-tech application, and public-private partnerships. The country has a strong knowledge base at university and business levels, which will drive significant investments by leading market players in diabetes care devices.
For instance, in December 2021, Novo Nordisk A/S announced an investment of more than USD 2.58 billion in the development of three new manufacturing facilities and the expansion of an existing one at Kalundborg, Denmark. In addition, presence of public companies such as Coloplast Corp. is expected to increase investment in this region.
Moreover, as per Danish Medical Journal, in Denmark, around 300,000 patients suffer from diabetes, whereas approximately 22,000 suffer from diabetic foot ulcers. The number of people suffering from diabetic foot ulcers is estimated to increase by 3,000 per year, which is anticipated to increase the demand for wound dressing products, thereby propelling the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Denmark diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account